At upcoming industry conferences, Sirnaomics will present the most recent developments on the GalAheadTM therapeutic platform.
A leading biopharmaceutical company in the discovery and development of RNAi therapeutics, Sirnaomics Ltd. (the “Company” or “Sirnaomics,” stock code: 2257.HK) announced today that it GO→